# VEOZAH
> **NDA216578** · New Drug Application · Sponsor: ASTELLAS · Approved 2023-05-12
## Drug
- **FDA Application Number:** NDA216578
- **Application type:** New Drug Application
- **Brand name:** VEOZAH
- **Generic name:** FEZOLINETANT
- **Active ingredients:** FEZOLINETANT
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ASTELLAS
- **Manufacturer:** Astellas Pharma US, Inc.
- **First approval:** 2023-05-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216578)
---
*AI Analytics · CC0 1.0*